Derek Collison

Founder & CEO at Synadia. Creator of NATS.io

📍 Beverly Hills, California, United States🔄 Updated September 2026💼 7 investments📅 13 years investing🗓 Last invested Oct 2020𝕏 @upgrade_to_unlock
VC🌍 United States
7
Total investments
2
Early stage
1
Mid stage
1
Late stage
13y
Years active

Portfolio

6 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Board Member
Oct 2020
RONALD REGAN UCLA MEDICAL CENTER is a medical practice company based out of 8603 JELLICO AVE, Northridge, California, United States.
Investor
Aug 2020
Vaxxinity is a U.S.-based global biotechnology company pioneering a new class of medicines to democratize health. Headquartered in Dallas, TX, with operations in the United States, Latin America, Europe and Asia, the company’s proprietary technology platform has enabled the innovation of synthetic peptide vaccines designed to prevent or treat infectious diseases, including COVID-19, and chronic diseases, including Alzheimer's, Parkinson’s, migraine, and hypercholesterolemia.. Vaxxinity has optimized its pipeline to achieve a potentially historic, global impact on human health. The key to the platform is the proprietary library of UBITh peptides, which are immunosilent, avoiding inflammation, and when linked to custom-designed target antigens, can elicit highly specific antibodies.
Investor
Dec 2016
Savonix is the only digital neuropsychology platform in the market. We empower patients, providers, payers, and researchers with cognitive solutions to fight against dementia. Clinically validated, our cloud-based platform allows users to screen for cognitive health directly from their mobile device. Privacy Statement: https://savonix.com/terms-and-privacy/ For a demonstration of the cognitive solutions we offer: https://savonix.com/contact/
Investor
Mar 2016
The Vicarious business has been acquired by Intrinsic, a robotics software and AI company at Alphabet. Together, we share an exciting mission to unlock the economic and creative potential of industrial robotics for millions of businesses, entrepreneurs and developers. Learn more about the work we will do together at www.intrinsic.ai. — Before joining Intrinsic, Vicarious built a thriving business as a turnkey robotics solutions integrator using AI to automate tasks too complex for traditional automation, by leveraging their deep expertise in neuroscience. Vicarious was founded in 2010 by Scott Phoenix and Dileep George, and backed by over $200M from investors like Jeff Bezos, Elon Musk, Mark Zuckerberg, and Samsung. Its technology has been published in peer-reviewed journals like Science and Science Robotics and featured by the New York Times, Wall Street Journal, MIT, Wired, and more.
Investor
Feb 2016
Xperiel is making the physical world digitally interactive. We're bringing the Real World Web to life.
Investor
Mar 2013
Heavybit is the leading early-stage investor in enterprise infrastructure. Since 2013, weve helped launch and scale visionary technical startups—from DevSecOps and feature flagging to AI code generation and beyond. We go hands-on from day 0, backing founders as they turn code into companies and build the future of software from the bottom up to the top down.
Experience · 10 entries
All (10)
Investments (7)
Founder (3)
Board (1)
2020
Board Member
Oct 2020
RONALD REGAN UCLA MEDICAL CENTER is a medical practice company based out of 8603 JELLICO AVE, Northridge, California, United States.
Investor
Aug 2020
Vaxxinity is a U.S.-based global biotechnology company pioneering a new class of medicines to democratize health. Headquartered in Dallas, TX, with operations in the United States, Latin America, Europe and Asia, the company’s proprietary technology platform has enabled the innovation of synthetic peptide vaccines designed to prevent or treat infectious diseases, including COVID-19, and chronic diseases, including Alzheimer's, Parkinson’s, migraine, and hypercholesterolemia.. Vaxxinity has optimized its pipeline to achieve a potentially historic, global impact on human health. The key to the platform is the proprietary library of UBITh peptides, which are immunosilent, avoiding inflammation, and when linked to custom-designed target antigens, can elicit highly specific antibodies.
2018
Founder and CEO
Jan 2018
Building the next generation of digital communications to unify cloud, edge and IoT.
2017
Founder & CEO
Dec 2017
Building the next generation of digital communications to unify cloud, edge and IoT.
Investor
Mar 2017
We know it’s a daunting task for today’s providers of services—like telcos, healthcare providers, governments and forward-thinking manufacturers—to add new IoT services to their existing offerings. Prodea enables existing and aspiring Service Providers to quickly add and integrate best-of-breed IoT Solutions which can be deployed across multiple vertical markets. Below is a synopsis of select examples of Prodea-enabled IoT services deployed across four vertical markets, or go here for an in-depth view.
Show all 10 entries ↓
Investment activity
2013–2020 · 7 investments
20131201632017120202
Recent (last 2 years)Earlier